The Philippine Food and Drug Administration (FDA) has granted CoronaVac, the Covid-19 vaccine of China's Sinovac, an emergency use authorization (EUA) today.
But the FDA said that CoronaVac's efficacy rate is only 50.4 percent.
FDA said it was not fit for health workers who are always exposed to Covid-19 patients nor for senior citizens who have comorbidities.
FDA also said that the Sinovac vaccine should only be administered to clinically healthy individuals aged 18 to 59 years old.
